Phase I/II Clinical Trial of NC-6004 in Combination with 5-FU and Cetuximab as First-line Treatment in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of The Head and Neck
Latest Information Update: 30 Apr 2019
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin (Primary) ; Fluorouracil (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors NanoCarrier
- 25 Apr 2019 Status changed from active, no longer recruiting to completed.
- 22 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Sep 2018 This trial has been completed in Hungary.